5 years ago
EvoNetix Raises $30M for Gene Synthesis Platform
UK-based synthetic biology company Evonetix has closed a $30m Series B funding round led by Foresite Capital
The company will use the funds to accelerate internal technology development and increase headcount.
ProblemBiotechnology
"scaling and accelerating the process of DNA synthesis for various industries"
Solution
"developing a desktop platform with a silicon chip that controls the synthesis of DNA in parallel, achieving high accuracy, speed, and scalability"